Synergistic Effects of 1 h Post-Load Plasma Glucose and Smoking on Arterial Stiffness in Apparently Healthy Men: A Cross-sectional Study.
1h post-load plasma glucose
Arterial stiffness
Brachial–ankle pulse wave velocity
Oral glucose tolerance test
Smoking
Journal
Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298
Informations de publication
Date de publication:
01 Jun 2019
01 Jun 2019
Historique:
pubmed:
20
11
2018
medline:
4
12
2019
entrez:
20
11
2018
Statut:
ppublish
Résumé
One-hour post-load plasma glucose (1h-PG) during an oral glucose tolerance test and smoking are associated with arterial stiffness. However, it remains unknown whether there are synergistic effects of these two factors on arterial stiffness. This study aimed to investigate the interaction between 1h-PG and smoking in relation to brachial-ankle pulse wave velocity (baPWV) in young men with normal glucose tolerance (NGT). The study included 25-, 30-, 35-, 40-, and 45-year-old non-industrial male workers (n=2189) who underwent a detailed health check-up. Normotensive participants with NGT and taking no medication were included. A univariate linear regression analysis showed that 1h-PG correlated with baPWV (r=0.13, p<0.001), but the correlation was not significant in the multivariate analysis (β=0.02, p=0.24). However, we found a significant interaction between 1h-PG levels and smoking status in relation to baPWV (p=0.048). Therefore, further analyses were conducted in nonsmokers and smokers. A multivariate linear regression analysis revealed that 1h-PG significantly correlated with baPWV in smokers (β=0.11, p=0.02), but not in nonsmokers (β=0.01, p=0.79). The correlation remained significant even after adjustment for the number of cigarettes smoked per day (β=0.096, p=0.048) or the Brinkman index (β=0.097, p=0.043). A significant interaction between 1h-PG and smoking in relation to baPWV was found in apparently healthy men younger than 50 years old.
Identifiants
pubmed: 30449816
doi: 10.5551/jat.46193
pmc: PMC6545458
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
505-512Références
Lancet. 1999 Aug 21;354(9179):617-21
pubmed: 10466661
Eur J Clin Invest. 2001 Dec;31(12):1013-4
pubmed: 11903484
Hypertens Res. 2002 May;25(3):359-64
pubmed: 12135313
Int J Clin Pract Suppl. 2002 Jul;(129):59-64
pubmed: 12166609
Circulation. 2002 Oct 15;106(16):2067-72
pubmed: 12379575
Hypertension. 2003 Jan;41(1):183-7
pubmed: 12511550
Circulation. 2003 Apr 29;107(16):2089-95
pubmed: 12695300
Hypertension. 2004 Feb;43(2):176-81
pubmed: 14698999
Arterioscler Thromb Vasc Biol. 2005 May;25(5):932-43
pubmed: 15731494
Lancet. 2006 Aug 19;368(9536):647-58
pubmed: 16920470
Am J Hypertens. 2006 Sep;19(9):897-901
pubmed: 16942930
J Am Coll Cardiol. 2007 Jul 3;50(1):1-13
pubmed: 17601538
Diabetes. 2008 May;57(5):1349-54
pubmed: 18299315
Diabetes Res Clin Pract. 2008 Sep;81(3):284-9
pubmed: 18674839
Atherosclerosis. 2009 Nov;207(1):245-9
pubmed: 19410252
Prim Care Diabetes. 2009 Nov;3(4):205-9
pubmed: 19875348
Diabetes Care. 2009 Nov;32 Suppl 2:S429-31
pubmed: 19875595
Diabetes Care. 2010 Feb;33(2):411-3
pubmed: 19918010
Diabetes Care. 2010 Sep;33(9):2090-7
pubmed: 20805281
Diabetes Care. 2011 Jun;34(6):1406-11
pubmed: 21515837
Hypertension. 2012 Aug;60(2):556-62
pubmed: 22733468
Diabet Med. 2012 Dec;29(12):e457-60
pubmed: 23002926
PLoS One. 2012;7(9):e44470
pubmed: 23028545
Acta Diabetol. 2014 Dec;51(6):927-32
pubmed: 24619654
Diabetes Care. 2015 Jan;38 Suppl:S8-S16
pubmed: 25537714
Atherosclerosis. 2015 Feb;238(2):370-9
pubmed: 25558032
N Engl J Med. 2015 Oct 29;373(18):1720-32
pubmed: 26510021
Hypertension. 2017 Jun;69(6):1045-1052
pubmed: 28438905
J Atheroscler Thromb. 2018 Feb 1;25(2):178-185
pubmed: 28740031
Diab Vasc Dis Res. 2018 Jan;15(1):39-45
pubmed: 29081239
Lancet. 1971 Sep 18;2(7725):632-4
pubmed: 4105947
Arterioscler Thromb. 1994 Dec;14(12):1946-50
pubmed: 7981184